KLAS Contact
Contact KLAS
Contact KLAS
2022 BEST IN KLAS
Preferences
Related Series
2018
2012
Related Articles
Shared Smart Devices 2020
The Latest Generation of Devices for Nurses
Author
Paul Hess
Author
Jonathan Christensen
Current Time Inside Cache Tag Helper: 8/17/2022 4:54:27 PM and Model.reportId = 1569
Shared smart devices are devices used by multiple care team members—mainly nurses but also some hospitalists and therapists—within the walls of the hospital. These devices are increasingly popular in healthcare as a means of improving communication and potentially consolidating the nurse toolbelt. In this high-level update to KLAS’ 2018 clinical mobility report, KLAS spoke to organizations using the latest devices from Apple, Vocera, or Zebra (about 10 customers per device). Have new models addressed older versions’ challenges with connectivity, call quality, durability, and battery life? Which devices best meet customer needs? Do Apple and Zebra continue with high mindshare, and what (if any) adoption have Ascom, Samsung, or Spectralink generated? Where does Vocera fit in the market landscape?if you don't have a login, getting started is easy.
Key Findings:
- Apple a Solid Performer; Healthcare-Specific Zebra Strong with Some Limitations; Vocera Good for Communication, Limited Elsewhere
- Apple Most Broadly Considered Thanks to Epic Integration; Zebra Strongest Android Option; Some Spectralink Consideration; Samsung Infrequently Considered
- Zebra Used for Most Applications; Apple Used Broadly; Vocera Deployments Still Early
- Vendor Bottom Lines
Writer
Amanda Wind Smith
Designer
Jess Wallace-Simpson
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.